MINAPHARM Pharmaceuticals reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was EGP 1,071.13 million compared to EGP 861.3 million a year ago. Net income was EGP 87.72 million compared to EGP 134.3 million a year ago. Basic earnings per share from continuing operations was EGP 7.92 compared to EGP 11.31 a year ago.
For the six months, sales was EGP 2,043.37 million compared to EGP 1,660.55 million a year ago. Net income was EGP 137.65 million compared to EGP 264.81 million a year ago. Basic earnings per share from continuing operations was EGP 11.41 compared to EGP 21.5 a year ago.